RRG

RRG (Rare Renal Group) is a specialized healthcare and research organization focused on the management and study of rare kidney diseases. The company provides a comprehensive clinical and research infrastructure that connects patients, clinicians, and researchers to improve diagnostics and therapeutic outcomes for orphan renal conditions. RRG maintains extensive patient registries and biobanks, facilitating large-scale genomic and clinical studies to identify novel biomarkers and therapeutic targets. Their work primarily supports the development of precision medicine approaches for conditions such as atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy. By integrating clinical care with advanced research, RRG serves as a critical hub for the rare renal disease community in the United Kingdom and beyond.